Thermo Fisher Scientific announced that it has teamed with Helix and Rosalind, Inc. on a National Institutes of Health (NIH)-supported project to develop a new SARS-CoV-2 genotyping method allowing for more rapid and cost-effective identification of virus variants...
A new initiative launched by the National Institutes of Health’s National Cancer Institute (NCI) on March 21 will bring a state-of-the art diagnostic option to children, adolescents, and young adults who have recently been diagnosed with central nervous system tumors....
On March 23, Thermo Fisher Scientific announced it is partnering with population genomics company Helix, bioinformatics company Rosalind, and the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative to identify SARS-CoV-2 variants...
On March 15, President Biden signed the Consolidated Appropriations Act, 2022 into law, an omnibus bill that sets the budgets for all federal agencies for the rest of FY2022. The bill includes a $2 billion increase for the National Institutes of Health (NIH), bringing...